Accretive definition

Accretive means that the projected pro forma consolidated EBITDA (calculated on a per share basis) of the Maker and the other constituent entity(ies) in such transaction, and the respective Consolidated Subsidiaries of the Maker and such constituent entity(ies) for the twelve calendar month period immediately following such transaction, is not less than the projected EBITDA (calculated on a per share basis), on a consolidated basis, of the Maker and its Consolidated Subsidiaries for the same period, all as presented in the Financial Projections.

AI-Powered Contracts

Draft, Review & Redline at the Speed of AI

Accretive has the meaning stated in the preamble to this Agreement.

Accretive means, with respect to any acquisition of any Person, entity or line of business (a “Target”), the Borrower has reasonably determined that based on its analysis of the Target’s financial performance and business and applying an equivalent methodology of accounting analysis as used for calculating its Reported EBITDA hereunder to the Target, (i) Target’s Reported EBITDA (as calculated on a stand-alone basis as applied as if the Target was the sole Loan Party), (x) for the twelve months immediately preceding such proposed acquisition, was greater than zero and (y) for the twelve months immediately following such acquisition, taking into account any and all assumed or incurred liabilities or Indebtedness in connection with such acquisition, is not projected to result in a reduction of the Borrower’s Reported EBITDA or Reported Adjusted EBITDA for such period and (ii) the Consolidated First Lien Net Leverage Ratio on a Pro Forma Basis as determined in accordance with Section 1.09 after giving effect to such transaction, shall be, as of the last day of the most recently ended Test Period and shall be projected at all times for a twelve month period after such acquisition to be, less than the Consolidated First Lien Net Leverage Ratio immediately prior to giving effect to such transaction.

Examples of Accretive in a sentence

This Nonstatutory Stock Option Award is granted to the Participant on a stand-alone basis, outside the Accretive Health, Inc.
This Restricted Stock Award is granted to the Participant on a stand-alone basis, outside the Accretive Health, Inc.
AMENDED AND RESTATED MASTER PROFESSIONAL SERVICES AGREEMENT between Ascension Health and Accretive Health, Inc.
Except as otherwise provided in this Agreement, all notices, requests, claims, demands, waivers and other communications required or permitted under this Agreement shall be in writing and shall be mailed by reliable overnight delivery service or delivered by hand, facsimile or messenger as follows: if to the Company: Accretive Health, Inc.
A description of the property with respect to which the election is being made: [ ] shares of common stock of Accretive Health, Inc., par value $0.01.
As of the date hereof, the Board of Directors of the Company is currently comprised of the following eight (8) persons: ▇▇▇▇▇▇ ▇▇▇▇▇▇ Co-Chairman Art Spiegel Co-Chairman ▇▇▇▇▇▇▇ ▇▇▇▇▇ Designee of Accretive ▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇.
For purposes of this Agreement, the “Company” shall mean Accretive Health, Inc.
Each of Accretive and Oak Hill, to the extent they have a right to designate one or more directors to the Company’s Board of Directors pursuant to Section 2.1, can choose to have one representative on each such committee, if any.
For the avoidance of doubt, neither the Trust nor the Fund shall have an obligation to pay any Fees to Accretive under this Agreement or otherwise for the use of the Index or the Names.
This Restricted Stock Award is granted to the Participant under the Amended and Restated Accretive Health, Inc.

More Definitions of Accretive

Accretive means, with respect to any acquisition of any Person, entity or line of business (a “Target”), the Company has reasonably determined that based on its analysis of the Target’s financial performance and business and applying an equivalent methodology of accounting analysis as used for calculating its Reported EBITDA hereunder to the Target, (i) Target’s Reported EBITDA (as calculated on a stand-alone basis as applied as if the Target was the sole Note Party), (x) for the twelve months immediately preceding such proposed acquisition, was greater than zero and (y) for the twelve months immediately following such acquisition, taking into account any and all assumed or incurred liabilities or Indebtedness in connection with such acquisition, is not projected to result in a reduction of the Company’s Reported EBITDA or Reported Adjusted EBITDA for such period and (ii) the Consolidated First Lien Net Leverage Ratio on a Pro Forma Basis as determined in accordance with Section 13.20 after giving effect to such transaction shall be as of the last day of the most recently ended Test Period, and shall be projected at all times for a twelve month period after such acquisition to be, less than the Consolidated First Lien Net Leverage Ratio immediately prior to giving effect to such transaction.

Accretive means, with respect to a Merger, that diluted earnings per share or the After Tax Cash Flow of the Person surviving the Merger, as presented in the pro forma consolidated or combined income statements for such surviving Person, prepared on a reasonable basis (which may include certain adjustments for revenues and expenses), must exceed the Company's diluted earnings per share or After Tax Cash Flow for the period used for such determination. Such pro forma presentation shall be opined on by a nationally recognized investment banking firm separately or as part of its fairness opinion with respect to the Merger in question.

Accretive means any Acquisition that is, on a pro forma basis, accretive to the EBITDA of the Company and its Subsidiaries (as determined by the Company in good faith).

Accretive means that following the Acquisition, Borrower and the acquired Person have increased net income and increased cash flow.

Accretive has the meaning set forth in the Recitals.

Accretive means, with respect to a Proposed Acquisition, that the projected pro forma consolidated EBITDA (calculated on a per share basis) of Maker and the other constituent entity(ies) in such transaction, and the respective Consolidated Subsidiaries of Maker and such constituent entity(ies) for the twelve calendar month period immediately following such transaction, is not less than the projected EBITDA (calculated on a per share basis), on a consolidated basis, of Maker and its Consolidated Subsidiaries for the same period, all as presented in the Financial Projections.